Novavax

NVAX • NASDAQ • Stock Fundamentals

Novavax is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO John Charles Jacobs, with a market cap of $1.5B.

Market Cap$1.5B

Employees2.0K

CEOJohn Charles Jacobs

CountryUnited States of America

Healthcare

Biotechnology

Most Recent EarningsMay 6, 2026 · 1 month 8 days agoQ1 2026

Next EarningsAug 5, 2026 · in 2 monthsBefore Market Open · Q2 2026

Financials

Based on Q1 2026 filing

Common questions about Novavax

Novavax (NVAX) has a market capitalization of $1.5B and trades on NASDAQ.

Novavax has approximately 1,992 employees.